Fate Therapeutics

History

YearDetail
2007 The company was founded in 2007 and is headquartered in San Diego, U.S.
2022 Fate Therapeutics expanded Solid Tumor's collaboration with ONO Pharmaceutical for iPSC-derived CAR NK and CAR T-cell cancer Immunotherapies.
AI Sentiment